MedPath

Erazin

Brand Name: Erazin

Generic Name: Cetirizine Hydrochloride

Active
Registration Number

DRP-3522-11

Dosage Form

Syrup

Issuance Date

July 1, 2024

Expiry Date

February 1, 2027

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength5 mg/5 mL
PackagingAmber Glass Bottle x 60 mL / (Box of 1's)

Classification

C
Classification
Over-the-Counter (OTC) Drug
P
Pharmacologic
H1-Receptor Antagonist (Antihistamine)
A
Application
CLIDP Conversion
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Cetirizine HydrochlorideActive
Monograph: Cetirizine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform